Wedbush Starts Turning Point Therapeutics Inc. (TPTX) at Outperform

September 9, 2019 4:13 PM EDT
Get Alerts TPTX Hot Sheet
Price: $61.11 -2.43%

Rating Summary:
    11 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 26 | New: 41
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten initiates coverage on Turning Point Therapeutics Inc. (NASDAQ: TPTX) with a Outperform rating and a price target of $63.00.

For an analyst ratings summary and ratings history on Turning Point Therapeutics Inc. click here. For more ratings news on Turning Point Therapeutics Inc. click here.

Shares of Turning Point Therapeutics Inc. closed at $42.75 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage